These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 737983)

  • 41. [Iatrogenic diabetic coma. Contribution to adverse effects of cytostatic therapy].
    Barb U; Vielberg H
    Strahlentherapie; 1973 Feb; 145(2):234-7. PubMed ID: 4694661
    [No Abstract]   [Full Text] [Related]  

  • 42. Advanced cancer: New concepts of medical therapy.
    Geriatrics; 1973 Nov; 28(11):51-72. PubMed ID: 4796352
    [No Abstract]   [Full Text] [Related]  

  • 43. [Theory and practice of systemic cancer therapy].
    Nagel GA
    Wien Med Wochenschr; 1972 Nov; 122(47):692-6. PubMed ID: 4634241
    [No Abstract]   [Full Text] [Related]  

  • 44. [Sequential chemotherapy based on the hypothesis of a circadian rhythm of tumor proliferation].
    Focan C
    Nouv Presse Med; 1975 Nov; 4(38):2709-12. PubMed ID: 1105421
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Endocrine and cytostatic treatment of metastazing breast carcinoma in the female].
    Nowakowski H
    Strahlentherapie; 1974 Apr; 147(4):388-400. PubMed ID: 4409449
    [No Abstract]   [Full Text] [Related]  

  • 46. [Experiences with cytostatic treatment of malignant tumors].
    Siering H; Felsch G; Barthel E
    Z Gesamte Inn Med; 1976 Feb; 31(3):65-9. PubMed ID: 960897
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Melphalan and methotrexate in advanced breast cancer.
    Priestman TJ; Salaman PF
    Cancer Treat Rep; 1978 Dec; 62(12):2111-2. PubMed ID: 751718
    [No Abstract]   [Full Text] [Related]  

  • 48. Cancer of the breast. Nursing care.
    Krumm S
    Major Probl Clin Surg; 1979; 5():587-612. PubMed ID: 459556
    [No Abstract]   [Full Text] [Related]  

  • 49. In vitro evaluation of myelotoxicity induced by antineoplastic drugs.
    Viano I; Silvestro L; Giaccone G; Compagnoni G; Donadio M; Ferrati P; Dianzani C; Genazzani E
    Chemioterapia; 1986 Jun; 5(3):147-9. PubMed ID: 3013432
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The use of recombinant human granulocyte-macrophage colony-stimulating factor in autologous bone marrow transplantation.
    Peters WP; Kurtzberg J; Atwater S; Borowitz M; Rao M; Currie M; Gilbert C; Shpall EJ; Jones RB; Ross M
    Prog Clin Biol Res; 1990; 338():121-8. PubMed ID: 2189135
    [No Abstract]   [Full Text] [Related]  

  • 51. [Thoughts about the present state of tumour chemotherapy (author's transl)].
    Rieche K
    Arch Geschwulstforsch; 1976; 46(3):225-9. PubMed ID: 971043
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Tumor of the breast].
    Neretto G
    Minerva Ginecol; 1981; 33(2-3):289-91. PubMed ID: 7254661
    [No Abstract]   [Full Text] [Related]  

  • 53. Immunologic and chemotherapeutic parameters in a model breast tumor system.
    Rugmann RA; Stolfi RL; Hayworth PE; Martin DS
    Cancer Chemother Rep 2; 1974 Mar; 4(1):25-32. PubMed ID: 4826497
    [No Abstract]   [Full Text] [Related]  

  • 54. Combination chemotherapy in recurrent carcinoma of the breast.
    Stocks LH; Shingleton WW
    N C Med J; 1975 Nov; 36(11):673-5. PubMed ID: 1061862
    [No Abstract]   [Full Text] [Related]  

  • 55. [Do anabolic steroids protect bone marrow during cytostatic therapy?].
    Kopera H
    Med Klin; 1980 Jul; 75(15):539-43. PubMed ID: 7001201
    [No Abstract]   [Full Text] [Related]  

  • 56. Adjuvant chemotherapy for breast cancer.
    Schnipper LE; Come SE
    Compr Ther; 1980 Oct; 6(10):42-7. PubMed ID: 7449364
    [No Abstract]   [Full Text] [Related]  

  • 57. Serum muramidase in patients with neutropenia.
    Vietzke WM; Perillie PE; Finch SC
    Yale J Biol Med; 1972 Oct; 45(5):457-62. PubMed ID: 4635683
    [No Abstract]   [Full Text] [Related]  

  • 58. Splenic granulopoietic morphology in laboratory rats after experimental induction of marrow hypoplasia.
    Berger J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(5):604-9. PubMed ID: 6083934
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Medical treatment of malignant bone tumors (carcinolytics, hormonotherapy, immunotherapy)].
    Clavel B
    Sem Hop; 1974 Jan; 50(4):287-95. PubMed ID: 4368180
    [No Abstract]   [Full Text] [Related]  

  • 60. The risk of adjuvant chemotherapy.
    Gürtler R
    Arch Geschwulstforsch; 1978; 48(7):644-52. PubMed ID: 736745
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.